Description
A cell-permeable carbazolic compound which directly interacts with and stabilizes CRY1 and CRY2, preventing ubiquitin-dependent degradation while lengthening the circadian period (IC50 = 0.82-14 μM); inhibits glucagon-induced gluconeogenesis in primary hepatocytes
Formal name: N-[3-(9H-carbazol-9-yl)-2-hydroxypropyl]-N-(2-furanylmethyl)-methanesulfonamide
Synonyms:
Molecular weight: 398.5
CAS: 309928-48-1
Purity: ≥98%
Formulation: A crystalline solid
Product Type||Research Area|Endocrinology & Metabolism|Carbohydrate Metabolism||Research Area|Neuroscience